Ignite Creation Date:
2024-07-17 @ 11:17 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493370
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-06-26
Brief Title:
Intravenous Ascorbate Plus GemcitabineCarboplatin A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
Sponsor:
University of Kansas Medical Center
Organization:
University of Kansas Medical Center
Organization Data
Organization:
University of Kansas Medical Center
Class:
OTHER
Study ID:
IIT-2024-IVC GC MIBC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Kansas Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
John Taylor
Responsible Party Title:
Director of Basic Urologic Research
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Kansas Medical Center
Old Name:
None
Old Organization:
None